Recent Finacing
Recent Raise
Tavotek Biotherapeutics develops antibody and multicyclic peptide therapeutics for oncology, autoimmune, and inflammatory diseases using platforms—TavoSelect phage-display, TavoPrecise tissue-targeting, and TavoMIP—operating R&D centers in Lower Gwynedd, PA and Suzhou
